The North America Cardiac Marker Testing Market would witness market growth of 7.6% CAGR during the forecast period (2022-2028).
Cardiac biomarkers are crucial for the prompt, accurate diagnosis, treatment, and prognosis of the acute coronary syndrome. The myocardial enzymes, a number of myocardial proteins, peptides, and various other substances were among the many biomarkers that were initially studied. The stable molecules known as microRNAs, which can be found in circulation, are the newest addition to the repertoire.
There are four categories that are identified to be involved in the regulation of the circulatory system, and some of them have promise as early and specific markers of cardiac dysfunction and acute coronary syndrome. The use of microRNAs may provide tailored, precise treatment, as in other areas of medicine. Since now, a multifaceted strategy involving various markers for which troponins are required appears to be the optimal course of action.
Cardiac disorders are the primary cause of death in the United States. In the United States, heart disease was the cause of 1 in 5 fatalities in 2020, taking the lives of almost 697,000 people. Heart disease cost the US $229 billion between 2017 and 2018. This covers the cost of prescription medications, medical expenses, and lost wages due to mortality. The high volume of cardiac marker testing would be performed in the North America region due to this increased prevalence of cardiovascular disorders.
The US market dominated the North America Cardiac Marker Testing Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $2,149.2 million by 2028.The Canada market is poised to grow at a CAGR of 10.1% during (2022 - 2028). Additionally, The Mexico market would witness a CAGR of 9.1% during (2022 - 2028).
Based on Disease, the market is segmented into Myocardial Infarction, Congestive Heart Failure, Atherosclerosis, Acute Coronary Syndrome and Ischemia. Based on End User, the market is segmented into Laboratory Testing Facilities, Point-of-Care Testing Facilities and Academic Institutions. Based on Product, the market is segmented into Reagents & Kits and Instruments. Based on Biomarker Type, the market is segmented into Troponin I & T, Creatine kinase-MB(CK-MB), Natriuretic peptide (Bnp Or Nt-Probnp), Myoglobin, High-sensitivity C-reactive protein(hs-CRP) and Others. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
Free Valuable Insights: The Global Cardiac Marker Testing Market is Estimated to reach $8.1 Billion by 2028, at a CAGR of 8.3%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include F. Hoffmann-La Roche Ltd., Abbott Laboratories, Danaher Corporation, Siemens Healthineers AG (Siemens AG), PerkinElmer, Inc., BioMérieux S.A., Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., Thermo Fisher Scientific, Inc., and DiaSorin S.p.A.
Scope of the Study
Market Segments Covered in the Report:
By Disease
- Myocardial Infarction
- Congestive Heart Failure
- Atherosclerosis
- Acute Coronary Syndrome
- Ischemia
By End User
- Laboratory Testing Facilities
- Point-of-Care Testing Facilities
- Academic Institutions
By Product
- Reagents & Kits
- Instruments
By Biomarker Type
- Troponin I & T
- Creatine kinase-MB(CK-MB)
- Natriuretic peptide (Bnp Or Nt-Probnp)
- Myoglobin
- High-sensitivity C-reactive protein(hs-CRP)
- Others
By Country
- US
- Canada
- Mexico
- Rest of North America
Key Market Players
List of Companies Profiled in the Report:
- F. Hoffmann-La Roche Ltd.
- Abbott Laboratories
- Danaher Corporation
- Siemens Healthineers AG (Siemens AG)
- PerkinElmer, Inc.
- BioMérieux S.A.
- Becton, Dickinson and Company
- Bio-Rad Laboratories, Inc.
- Thermo Fisher Scientific, Inc.
- DiaSorin S.p.A.
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Cardiac Marker Testing Market, by Disease
1.4.2 North America Cardiac Marker Testing Market, by End User
1.4.3 North America Cardiac Marker Testing Market, by Product
1.4.4 North America Cardiac Marker Testing Market, by Biomarker Type
1.4.5 North America Cardiac Marker Testing Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition & Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Competition Analysis - Global
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Acquisition and Mergers
3.2.4 Trails & Approvals
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2018-2022)
Chapter 4. North America Cardiac Marker Testing Market by Disease
4.1 North America Myocardial Infarction Market by Country
4.2 North America Congestive Heart Failure Market by Country
4.3 North America Atherosclerosis Market by Country
4.4 North America Acute Coronary Syndrome Market by Country
4.5 North America Ischemia Market by Country
Chapter 5. North America Cardiac Marker Testing Market by End User
5.1 North America Laboratory Testing Facilities Market by Country
5.2 North America Point-of-Care Testing Facilities Market by Country
5.3 North America Academic Institutions Market by Country
Chapter 6. North America Cardiac Marker Testing Market by Product
6.1 North America Reagents & Kits Market by Country
6.2 North America Instruments Market by Country
Chapter 7. North America Cardiac Marker Testing Market by Biomarker Type
7.1 North America Troponin I & T Market by Country
7.2 North America Creatine kinase-MB(CK-MB) Market by Country
7.3 North America Natriuretic peptide (Bnp Or Nt-Probnp) Market by Country
7.4 North America Myoglobin Market by Country
7.5 North America High-sensitivity C-reactive protein(hs-CRP) Market by Country
7.6 North America Others Market by Country
Chapter 8. North America Cardiac Marker Testing Market by Country
8.1 US Cardiac Marker Testing Market
8.1.1 US Cardiac Marker Testing Market by Disease
8.1.2 US Cardiac Marker Testing Market by End User
8.1.3 US Cardiac Marker Testing Market by Product
8.1.4 US Cardiac Marker Testing Market by Biomarker Type
8.2 Canada Cardiac Marker Testing Market
8.2.1 Canada Cardiac Marker Testing Market by Disease
8.2.2 Canada Cardiac Marker Testing Market by End User
8.2.3 Canada Cardiac Marker Testing Market by Product
8.2.4 Canada Cardiac Marker Testing Market by Biomarker Type
8.3 Mexico Cardiac Marker Testing Market
8.3.1 Mexico Cardiac Marker Testing Market by Disease
8.3.2 Mexico Cardiac Marker Testing Market by End User
8.3.3 Mexico Cardiac Marker Testing Market by Product
8.3.4 Mexico Cardiac Marker Testing Market by Biomarker Type
8.4 Rest of North America Cardiac Marker Testing Market
8.4.1 Rest of North America Cardiac Marker Testing Market by Disease
8.4.2 Rest of North America Cardiac Marker Testing Market by End User
8.4.3 Rest of North America Cardiac Marker Testing Market by Product
8.4.4 Rest of North America Cardiac Marker Testing Market by Biomarker Type
Chapter 9. Company Profiles
9.1 Abbott Laboratories
9.1.1 Company Overview
9.1.2 Financial Analysis
9.1.3 Segmental and Regional Analysis
9.1.4 Research & Development Expense
9.1.5 Recent strategies and developments:
9.1.5.1 Product Launches and Product Expansions:
9.1.5.2 Approvals and Trials:
9.1.6 SWOT Analysis
9.2 Siemens Healthineers AG (Siemens AG)
9.2.1 Company Overview
9.2.2 Financial Analysis
9.2.3 Segmental and Regional Analysis
9.2.4 Research & Development Expense
9.2.5 Recent strategies and developments:
9.2.5.1 Partnerships, Collaborations, and Agreements:
9.2.5.2 Product Launches and Product Expansions:
9.2.5.3 Acquisition and Mergers:
9.2.6 SWOT Analysis
9.3 Becton, Dickinson and Company
9.3.1 Company Overview
9.3.2 Financial Analysis
9.3.3 Segmental and Regional Analysis
9.3.4 Research & Development Expense
9.4 F. Hoffmann-La Roche Ltd.
9.4.1 Company Overview
9.4.2 Financial Analysis
9.4.3 Segmental and Regional Analysis
9.4.4 Research & Development Expense
9.4.5 Recent strategies and developments:
9.4.5.1 Product Launches and Product Expansions:
9.5 Thermo Fisher Scientific, Inc.
9.5.1 Company Overview
9.5.2 Financial Analysis
9.5.3 Segmental and Regional Analysis
9.5.4 Research & Development Expense
9.5.5 Recent strategies and developments:
9.5.5.1 Partnerships, Collaborations, and Agreements:
9.5.5.2 Acquisition and Mergers:
9.6 Bio-Rad laboratories, Inc.
9.6.1 Company Overview
9.6.2 Financial Analysis
9.6.3 Segmental and Regional Analysis
9.6.4 Research & Development Expenses
9.6.5 Recent strategies and developments:
9.6.5.1 Acquisition and Mergers:
9.7 Danaher Corporation
9.7.1 Company Overview
9.7.2 Financial Analysis
9.7.3 Segmental and Regional Analysis
9.7.4 Research & Development Expense
9.8 DiaSorin S.p.A.
9.8.1 Company Overview
9.8.2 Financial Analysis
9.8.3 Regional Analysis
9.8.4 Research & Development Expenses
9.9 PerkinElmer, Inc.
9.9.1 Company Overview
9.9.2 Financial Analysis
9.9.3 Segmental and Regional Analysis
9.9.4 Research & Development Expense
9.9.5 Recent strategies and developments:
9.9.5.1 Product Launches and Product Expansions:
9.10. BioMérieux S.A.
9.10.1 Company Overview
9.10.2 Financial Analysis
9.10.3 Segmental and Regional Analysis
9.10.4 Research & Development Expenses
9.10.5 Recent strategies and developments:
9.10.5.1 Partnerships, Collaborations, and Agreements:
TABLE 1 North America Cardiac Marker Testing Market, 2018 - 2021, USD Million
TABLE 2 North America Cardiac Marker Testing Market, 2022 - 2028, USD Million
TABLE 3 Partnerships, Collaborations and Agreements– Cardiac Marker Testing Market
TABLE 4 Product Launches And Product Expansions– Cardiac Marker Testing Market
TABLE 5 Acquisition and Mergers– Cardiac Marker Testing Market
TABLE 6 Acquisition and Mergers– Cardiac Marker Testing Market
TABLE 7 North America Cardiac Marker Testing Market by Disease, 2018 - 2021, USD Million
TABLE 8 North America Cardiac Marker Testing Market by Disease, 2022 - 2028, USD Million
TABLE 9 North America Myocardial Infarction Market by Country, 2018 - 2021, USD Million
TABLE 10 North America Myocardial Infarction Market by Country, 2022 - 2028, USD Million
TABLE 11 North America Congestive Heart Failure Market by Country, 2018 - 2021, USD Million
TABLE 12 North America Congestive Heart Failure Market by Country, 2022 - 2028, USD Million
TABLE 13 North America Atherosclerosis Market by Country, 2018 - 2021, USD Million
TABLE 14 North America Atherosclerosis Market by Country, 2022 - 2028, USD Million
TABLE 15 North America Acute Coronary Syndrome Market by Country, 2018 - 2021, USD Million
TABLE 16 North America Acute Coronary Syndrome Market by Country, 2022 - 2028, USD Million
TABLE 17 North America Ischemia Market by Country, 2018 - 2021, USD Million
TABLE 18 North America Ischemia Market by Country, 2022 - 2028, USD Million
TABLE 19 North America Cardiac Marker Testing Market by End User, 2018 - 2021, USD Million
TABLE 20 North America Cardiac Marker Testing Market by End User, 2022 - 2028, USD Million
TABLE 21 North America Laboratory Testing Facilities Market by Country, 2018 - 2021, USD Million
TABLE 22 North America Laboratory Testing Facilities Market by Country, 2022 - 2028, USD Million
TABLE 23 North America Point-of-Care Testing Facilities Market by Country, 2018 - 2021, USD Million
TABLE 24 North America Point-of-Care Testing Facilities Market by Country, 2022 - 2028, USD Million
TABLE 25 North America Academic Institutions Market by Country, 2018 - 2021, USD Million
TABLE 26 North America Academic Institutions Market by Country, 2022 - 2028, USD Million
TABLE 27 North America Cardiac Marker Testing Market by Product, 2018 - 2021, USD Million
TABLE 28 North America Cardiac Marker Testing Market by Product, 2022 - 2028, USD Million
TABLE 29 North America Reagents & Kits Market by Country, 2018 - 2021, USD Million
TABLE 30 North America Reagents & Kits Market by Country, 2022 - 2028, USD Million
TABLE 31 North America Instruments Market by Country, 2018 - 2021, USD Million
TABLE 32 North America Instruments Market by Country, 2022 - 2028, USD Million
TABLE 33 North America Cardiac Marker Testing Market by Biomarker Type, 2018 - 2021, USD Million
TABLE 34 North America Cardiac Marker Testing Market by Biomarker Type, 2022 - 2028, USD Million
TABLE 35 North America Troponin I & T Market by Country, 2018 - 2021, USD Million
TABLE 36 North America Troponin I & T Market by Country, 2022 - 2028, USD Million
TABLE 37 North America Creatine kinase-MB(CK-MB) Market by Country, 2018 - 2021, USD Million
TABLE 38 North America Creatine kinase-MB(CK-MB) Market by Country, 2022 - 2028, USD Million
TABLE 39 North America Natriuretic peptide (Bnp Or Nt-Probnp) Market by Country, 2018 - 2021, USD Million
TABLE 40 North America Natriuretic peptide (Bnp Or Nt-Probnp) Market by Country, 2022 - 2028, USD Million
TABLE 41 North America Myoglobin Market by Country, 2018 - 2021, USD Million
TABLE 42 North America Myoglobin Market by Country, 2022 - 2028, USD Million
TABLE 43 North America High-sensitivity C-reactive protein(hs-CRP) Market by Country, 2018 - 2021, USD Million
TABLE 44 North America High-sensitivity C-reactive protein(hs-CRP) Market by Country, 2022 - 2028, USD Million
TABLE 45 North America Others Market by Country, 2018 - 2021, USD Million
TABLE 46 North America Others Market by Country, 2022 - 2028, USD Million
TABLE 47 North America Cardiac Marker Testing Market by Country, 2018 - 2021, USD Million
TABLE 48 North America Cardiac Marker Testing Market by Country, 2022 - 2028, USD Million
TABLE 49 US Cardiac Marker Testing Market, 2018 - 2021, USD Million
TABLE 50 US Cardiac Marker Testing Market, 2022 - 2028, USD Million
TABLE 51 US Cardiac Marker Testing Market by Disease, 2018 - 2021, USD Million
TABLE 52 US Cardiac Marker Testing Market by Disease, 2022 - 2028, USD Million
TABLE 53 US Cardiac Marker Testing Market by End User, 2018 - 2021, USD Million
TABLE 54 US Cardiac Marker Testing Market by End User, 2022 - 2028, USD Million
TABLE 55 US Cardiac Marker Testing Market by Product, 2018 - 2021, USD Million
TABLE 56 US Cardiac Marker Testing Market by Product, 2022 - 2028, USD Million
TABLE 57 US Cardiac Marker Testing Market by Biomarker Type, 2018 - 2021, USD Million
TABLE 58 US Cardiac Marker Testing Market by Biomarker Type, 2022 - 2028, USD Million
TABLE 59 Canada Cardiac Marker Testing Market, 2018 - 2021, USD Million
TABLE 60 Canada Cardiac Marker Testing Market, 2022 - 2028, USD Million
TABLE 61 Canada Cardiac Marker Testing Market by Disease, 2018 - 2021, USD Million
TABLE 62 Canada Cardiac Marker Testing Market by Disease, 2022 - 2028, USD Million
TABLE 63 Canada Cardiac Marker Testing Market by End User, 2018 - 2021, USD Million
TABLE 64 Canada Cardiac Marker Testing Market by End User, 2022 - 2028, USD Million
TABLE 65 Canada Cardiac Marker Testing Market by Product, 2018 - 2021, USD Million
TABLE 66 Canada Cardiac Marker Testing Market by Product, 2022 - 2028, USD Million
TABLE 67 Canada Cardiac Marker Testing Market by Biomarker Type, 2018 - 2021, USD Million
TABLE 68 Canada Cardiac Marker Testing Market by Biomarker Type, 2022 - 2028, USD Million
TABLE 69 Mexico Cardiac Marker Testing Market, 2018 - 2021, USD Million
TABLE 70 Mexico Cardiac Marker Testing Market, 2022 - 2028, USD Million
TABLE 71 Mexico Cardiac Marker Testing Market by Disease, 2018 - 2021, USD Million
TABLE 72 Mexico Cardiac Marker Testing Market by Disease, 2022 - 2028, USD Million
TABLE 73 Mexico Cardiac Marker Testing Market by End User, 2018 - 2021, USD Million
TABLE 74 Mexico Cardiac Marker Testing Market by End User, 2022 - 2028, USD Million
TABLE 75 Mexico Cardiac Marker Testing Market by Product, 2018 - 2021, USD Million
TABLE 76 Mexico Cardiac Marker Testing Market by Product, 2022 - 2028, USD Million
TABLE 77 Mexico Cardiac Marker Testing Market by Biomarker Type, 2018 - 2021, USD Million
TABLE 78 Mexico Cardiac Marker Testing Market by Biomarker Type, 2022 - 2028, USD Million
TABLE 79 Rest of North America Cardiac Marker Testing Market, 2018 - 2021, USD Million
TABLE 80 Rest of North America Cardiac Marker Testing Market, 2022 - 2028, USD Million
TABLE 81 Rest of North America Cardiac Marker Testing Market by Disease, 2018 - 2021, USD Million
TABLE 82 Rest of North America Cardiac Marker Testing Market by Disease, 2022 - 2028, USD Million
TABLE 83 Rest of North America Cardiac Marker Testing Market by End User, 2018 - 2021, USD Million
TABLE 84 Rest of North America Cardiac Marker Testing Market by End User, 2022 - 2028, USD Million
TABLE 85 Rest of North America Cardiac Marker Testing Market by Product, 2018 - 2021, USD Million
TABLE 86 Rest of North America Cardiac Marker Testing Market by Product, 2022 - 2028, USD Million
TABLE 87 Rest of North America Cardiac Marker Testing Market by Biomarker Type, 2018 - 2021, USD Million
TABLE 88 Rest of North America Cardiac Marker Testing Market by Biomarker Type, 2022 - 2028, USD Million
TABLE 89 Key Information – Abbott Laboratories
TABLE 90 Key Information – Siemens Healthineers AG
TABLE 91 Key information – Becton, Dickinson and Company
TABLE 92 KEY INFORMATION – F. Hoffmann-La Roche Ltd.
TABLE 93 Key Information – Thermo Fisher Scientific, Inc.
TABLE 94 Key Information – Bio-Rad Laboratories, Inc.
TABLE 95 Key Information – Danaher Corporation
TABLE 96 Key Information – DiaSorin S.p.A.
TABLE 97 key Information – PerkinElmer, Inc.
TABLE 98 Key information – BioMérieux S.A.
List of Figures
FIG 1 Methodology for the research
FIG 2 KBV Cardinal Matrix
FIG 3 Key Leading Strategies: Percentage Distribution (2018-2022)
FIG 4 Recent strategies and developments: Abbott Laboratories
FIG 5 Swot analysis: Abbott laboratories
FIG 6 Recent strategies and developments: Siemens Healthineers AG
FIG 7 Swot analysis: Siemens AG
FIG 8 Recent strategies and developments: Thermo Fisher Scientific, Inc.